Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-31 @ 11:00 AM
Study NCT ID:
NCT05034133
Status:
UNKNOWN
Last Update Posted:
2021-09-05
First Post:
2021-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
Sponsor:
Beijing Haidian Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-01
First Submit QC Date:
None
Study First Post Date:
2021-09-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-01
Last Update Post Date:
2021-09-05
Last Update Post Date Type:
ACTUAL